3D Bioprinting Market

3D Bioprinting Market Size, Share & Trends Analysis Report, By Technology (Extrusion-Based, Laser-Based, Inkjet-Based and Others), By Application (Drug Testing and Development, 3D Cell Culture, Tissue and Organ Regeneration, and Others) and Forecast 2019-2025

Published: Dec 2019 | Report Code: OMR2020057 | Category : Medical Devices | Delivery Format: /

The global 3D bioprinting market is expected to exhibit a CAGR of 13.5% during the forecast period. 3D bioprinting is an emerging area of regenerative medicine. It offers patient-specific spatial geometry, the positioning of several kinds of cells for the creation of tissue engineering scaffolds. This involves the printing of structures with the use of biomaterials, viable cells and biological molecules. 3D bioprinting can be used in a clinical setting for the development of regenerative scaffolds to suit the needs of patients. The major factors contributing to the growth of the global 3D bioprinting industry include increasing partnerships among players for the development of 3D bio-printed products and emerging demand for organ transplants.

3D bioprinting uses a typical layer-by-layer 3D printing techniques for the development of 3D tissues or structures utilized for tissue engineering or medicine. It is being used in regenerative medicine to meet the needs for tissues and 3D printed organs for transplantation. Most organs are still in the early stages of development. 3D bioprinting has shown success in the area of bone and skin. For instance, in May 2015, L'Oreal partnered with Organovo Bioprinting Company to 3D print human skin. Under the agreement, L'Oreal would use Organovo's NovoGen Bioprinting Platform to print skin tissue.

Segment Outlook

The global 3D bioprinting market is segmented on the basis of technology and application. Based on technology, the market is further classified into extrusion-based, laser-based, inkjet-based and others. Based on application, the market is further classified into drug testing and development, 3D cell culture, tissue and organ regeneration, and others.

Global 3D Bioprinting Market Share by Technology, 2018 (%)

Global 3D Bioprinting Market Share by Technology

3D Bioprinting Market: By Technology

Extrusion-based technology is expected to hold a significant share in the global 3D bioprinting market. The advantages of extrusion-based bioprinting in organ 3D bioprinting include high cell densities, large 3D constructs, and fast printing speeds. Beside polymeric solutions or hydrogels, extracellular matrices (ECMs) and cell aggregates can also be used as bio-inks. This method benefits in terms of ease of use, precision printing of complex geometries via computer-aided design (CAD), and multiple solidification methods. It is a simple method which is capable of printing various biomaterials and holds the ability to print high cell densities.

Regional Outlook

Geographically, the global 3D bioprinting market is further segmented into four major regions, such as North America, Europe, Asia-Pacific, and RoW. Advances in 3D bioprinting for tissue engineering coupled with rising partnerships for the development of 3D printed products are supporting to drive the market growth in these regions. Asia-Pacific is expected to exhibit the highest growth rate owing to increasing stem cell research activities in the region. Further, increasing demand for organ transplantation further gives a boost to the regional growth of the market.

 Global 3D Bioprinting Market Growth by Region, 2019-2025

Global 3D Bioprinting Market Growth by Region

North America is Anticipated to Hold the Largest Share in the Market 

North America is anticipated to hold the largest share in the market in 2018 owing to the presence of major players, such as Organovo Holdings, Inc., and EnvisionTec, Inc. in the region. Furthermore, significant researches on 3D bioprinting and rising number of organ transplantation are expected to boost the adoption of 3D printing technologies in the region. For instance, as per the Health Resources and Services Administration (HRSA), in the US, 36,528 organ transplants were performed in 2018. As of January 2018, more than 113,000 people are waiting for organ transplantation. Further, 20 people die each day waiting for a transplant in the US. 

3D bioprinting is considered as a hope for the patients waiting for organ transplantation. Due to this growing concern, the companies are significantly focusing on the development of tissues for treatment of a range of diseases, such as liver and kidney. These efforts will enable these companies to gain significant market share and thereby will contribute to the growth of the North American 3D bioprinting market.

Competitive Landscape

Some of the major players in the market include Organovo Holdings, Inc., 3D Systems Corp., CELLINK AB, Stratasys Ltd., and CollPlant Ltd. Partnerships and collaborations and product launches are considered as major strategies adopted by these companies to expand market share and gain a competitive advantage over competitors. For instance, in April 2017, 3D Systems and United Therapeutics Corp. announced a bioprinting agreement to develop solid-organ scaffolds for human transplants. 3D Systems believe that bioprinting offers a powerful opportunity and they are positioned with the widest portfolio of technologies to partner with companies to provide healthcare solutions of the future.

The Report Covers

  • Market value data analysis of 2018 and forecast to 2025.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global 3D bioprinting market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. By Geography

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis

3.2. Key Strategy Analysis

3.3. Key Company Analysis

3.3.1. 3D Systems Corp.

3.3.1.1. Overview

3.3.1.2. Financial Analysis

3.3.1.3. SWOT Analysis

3.3.1.4. Recent Developments

3.3.2. Organovo Holdings, Inc.

3.3.2.1. Overview

3.3.2.2. Financial Analysis

3.3.2.3. SWOT Analysis

3.3.2.4. Recent Developments

3.3.3. CELLINK AB

3.3.3.1. Overview

3.3.3.2. Financial Analysis

3.3.3.3. SWOT Analysis

3.3.3.4. Recent Developments

3.3.4. CollPlant Ltd.

3.3.4.1. Overview

3.3.4.2. Financial Analysis

3.3.4.3. SWOT Analysis

3.3.4.4. Recent Developments

3.3.5. Stratasys Ltd.

3.3.5.1. Overview

3.3.5.2. Financial Analysis

3.3.5.3. SWOT Analysis

3.3.5.4. Recent Developments

4. Market Determinants 

4.1. Motivators

4.2. Restraints

4.3. Opportunities 

5. Market Segmentation

5.1. Global 3D Bioprinting Market by Technology

5.1.1. Extrusion-based

5.1.2. Laser-based

5.1.3. Inkjet-based

5.1.4. Others (Microvalve-based and Stereolithography-based)

5.2. Global 3D Bioprinting Market by Application 

5.2.1. Drug Testing and Development

5.2.2. 3D Cell Culture

5.2.3. Tissue and Organ Regeneration

5.2.4. Others (Food Testing)

6. Regional Analysis

6.1. North America

6.1.1. United States

6.1.2. Canada

6.2. Europe

6.2.1. UK

6.2.2. Germany

6.2.3. Italy

6.2.4. Spain

6.2.5. France

6.2.6. Rest of Europe

6.3. Asia-Pacific

6.3.1. China

6.3.2. India

6.3.3. Japan

6.3.4. Rest of Asia-Pacific

6.4. Rest of the World

7. Company Profiles

7.1. 3D Bioprinting Solutions

7.2. 3D Systems Corp.

7.3. Advanced BioMatrix, Inc. 

7.4. Aleph Objects, Inc.

7.5. Allevi

7.6. Aspect Biosystems Ltd.

7.7. CELLINK AB

7.8. CollPlant Ltd.

7.9. Cyfuse Biomedical KK

7.10. Digilab, Inc.

7.11. EnvisionTEC, Inc.

7.12. Formlabs Inc.

7.13. GeSiM GmbH

7.14. Materialise NV

7.15. Medprin Biotech GmbH

7.16. Nano3D Biosciences, Inc.

7.17. Organovo Holdings Inc. 

7.18. Poietis

7.19. REGEMAT 3D S.L.

7.20. regenHU Ltd.

7.21. Regenovo Biotechnology Co., Ltd.

7.22. Stratasys, Ltd.

7.23. United Therapeutics Corp.

1. GLOBAL 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)

2. GLOBAL EXTRUSION-BASED 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

3. GLOBAL LASER-BASED 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

4. GLOBAL INKJET-BASED 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

5. GLOBAL OTHER 3D BIOPRINTING TECHNOLOGIES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

6. GLOBAL 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

7. GLOBAL 3D BIOPRINTING FOR DRUG TESTING AND DEVELOPMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

8. GLOBAL 3D BIOPRINTING FOR 3D CELL CULTURE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION) 

9. GLOBAL 3D BIOPRINTING FOR TISSUE AND ORGAN REGENERATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)  

10. GLOBAL 3D BIOPRINTING FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

11. GLOBAL 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)

12. NORTH AMERICAN 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

13. NORTH AMERICAN 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)

14. NORTH AMERICAN 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

15. EUROPEAN 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

16. EUROPEAN 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)

17. EUROPEAN 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

18. ASIA-PACIFIC 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

19. ASIA-PACIFIC 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)

20. ASIA-PACIFIC 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

21. REST OF THE WORLD 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)

22. REST OF THE WORLD 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

1. GLOBAL 3D BIOPRINTING MARKET SHARE BY TECHNOLOGY, 2018 VS 2025 (%)

2. GLOBAL 3D BIOPRINTING MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)

3. GLOBAL 3D BIOPRINTING MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)

4. US 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)

5. CANADA 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)

6. UK 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)

7. FRANCE 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)

8. GERMANY 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)

9. ITALY 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)

10. SPAIN 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)

11. ROE 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)

12. INDIA 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)

13. CHINA 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)

14. JAPAN 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)

15. REST OF ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)

16. REST OF THE WORLD 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)